Assignee
ARCHEMIX LLC
US·4 granted patents·4 pending applications·10 citations·filing 2007–2019
Top patents by PatentIndex Score
8 records- 0187US10947544B2Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX LLC·Filed 2019·Granted Mar 16, 2021·1 cites·5 claims
- 0284US9617546B2Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX LLC·Filed 2014·Granted Apr 11, 2017·4 cites·5 claims
- 0384US8362234B2Solid support reagents for synthesisARCHEMIX LLC·Filed 2007·Granted Jan 29, 2013·4 cites·19 claims
- 0475US8946184B2Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX LLC·Filed 2013·Granted Feb 3, 2015·1 cites·20 claims
- 0563US2015140120A1Stabilized aptamers to platelet derived growth factor and their use as oncology therapeuticsARCHEMIX LLC·Filed 2014·Application pending·0 cites
- 0662US2018030446A1Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX LLC·Filed 2017·Application pending·0 cites
- 0755US2016053266A1Stabilized Aptamers to Platelet Derived Growth Factor and Their Use as Oncology TherapeuticsARCHEMIX LLC·Filed 2015·Application pending·0 cites
- 0843US2017145416A1Complement Binding Aptamers and Anti-C5 Agents Useful in the Treatment of Ocular DisordersARCHEMIX LLC·Filed 2016·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →